Awakn Life Sciences Corp. (AWKNF) Research

Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.

Market snapshot

Symbol
AWKNF
Price
$0.07
Day change
0.00%
Market cap
$3.9M
P/E ratio
-0.28x
52-week range
0.04872-0.1334
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • ATI Physical Therapy, Inc. (ATIP)
  • BerGenBio ASA (BRRGF)
  • Pideka Group Inc. (CIMVF)
  • Delta 9 Cannabis Inc. (DLTNF)
  • Eve & Co Incorporated (EEVVF)
  • Empower Clinics Inc. (EPWCF)
  • Field Trip Health & Wellness Ltd. (FTHWF)
  • GABY Inc. (GABLF)

Open Awakn Life Sciences Corp. (AWKNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.